Heffter Research Institute | Study Publications

Future Research Cancer Distress Addiction Spirituality Neuroscience Research Publications

Future Research Cancer Distress
Addiction Spirituality
Neuroscience Research Publications

PUBLICATIONS

Heffter Research by Category

Sloshower J, Zeifman RJ, Guss J, Krause R, Safi-Aghdam H, Pathania S, Pittman B, D’Souza DC. Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial. Sci Rep. 2024 Apr 17;14(1):8833. doi: 10.1038/s41598-024-58318-x. PMID: 38632313; PMCID: PMC11024097.
Skosnik PD, Sloshower J, Safi-Aghdam H, Pathania S, Syed S, Pittman B, D’Souza DC. Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms. J Psychopharmacol. 2023 Jul;37(7):687-697. doi: 10.1177/02698811231179800. Epub 2023 Jun 30. PMID: 37392016.
Sloshower J, Skosnik PD, Safi-Aghdam H, Pathania S, Syed S, Pittman B, D’Souza DC. Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial. J Psychopharmacol. 2023 Jul;37(7):698-706. doi: 10.1177/02698811231154852. Epub 2023 Mar 20. PMID: 36938991.
Ching THW, Grazioplene R, Bohner C, Kichuk SA, DePalmer G, D’Amico E, Eilbott J, Jankovsky A, Burke M, Hokanson J, Martins B, Witherow C, Patel P, Amoroso L, Schaer H, Pittenger C, Kelmendi B. Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial. Front Psychiatry. 2023 Apr 25;14:1178529. doi: 10.3389/fpsyt.2023.1178529. PMID: 37181888; PMCID: PMC10166878.
von Rotz R, Schindowski EM, Jungwirth J, Schuldt A, Rieser NM, Zahoranszky K, Seifritz E, Nowak A, Nowak P, Jäncke L, Preller KH, Vollenweider FX. (2023) Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial. eClinicalMedicine 2023;56: 101809, doi.org/10. 1016/j.eclinm.2022. 101809.
Kelmendi B, Kichuk SA, DePalmer G, Maloney G, Ching THW, Belser A, Pittenger C. Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder: A case report. Heliyon. 2022 Dec 6;8(12):e12135. doi: 10.1016/j.heliyon.2022.e12135. PMID: 36536916; PMCID: PMC9758406.
Schindler EAD, Sewell RA, Gottschalk CH, Luddy C, Flynn LT, Zhu Y, Lindsey H, Pittman BP, Cozzi NV, D’Souza DC. Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial. Headache. 2022 Nov;62(10):1383-1394. doi: 10.1111/head.14420. Epub 2022 Nov 23. PMID: 36416492.
Anderson BT, Danforth A, Daroff R, Stauffer C, Ekman E, Agin-Liebes G, Trope A, Boden MT, Dilley J, Mitchell J, Woolley J. (2020) Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open- label safety and feasibility pilot study, EClinicalMedicine (2020), https://doi.org/10.1016/j.eclinm.2020.100538.
Sloshower J, Guss J, Krause R, Wallace R, Williams MT, Reed S, Skinta MD. (2020) Psilocybin-assisted therapy of major depressive disorder using acceptance and commitment therapy as a therapeutic frame. Journal of Contextual Behavioral Science 15, p 12-19. https://doi.org/10.1016/j.jcbs.2019.11.002.
Agin-Liebes GI, Malone T, Yalch MM, Mennenga SE, Ponté KL, Guss J, Bossis AP, Grigsby J, Fischer S, Ross S. (2020) Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer. Journal of Psychopharmacology Vol. 34(2) 155–166.
Malone TC, Mennenga SE, Guss J, Podrebarak SK, Owens LT, Bossis AP, Belser AB, Agin-Liebes G, Bogenschutz MP, Ross S. Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy. (2018) Front Pharmacol. 2018; 9: 256. Published online 2018 Apr 3. doi: 10.3389/fphar.2018.00256.
Swift TC, Belser AB, Agin-Liebes G, Devenot N, Terrana S, Friedman H, Guss J, Bossis A, Ross S. (2017). Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Distress. Journal of Humanistic Psychology. Advance online publication. doi:10.1177/0022167817715966
Belser AB, Agin-Liebes G, Swift TC, Terrana S, Devenot N, Friedman H, Guss J, Bossis A, Ross S. (2017). Patient experiences of psilocybin-assisted psychotherapy: An interpretative phenomenological analysis. Journal of Humanistic Psychology. Advance online publication. doi:10.1177/0022167817706884
Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, Cosimano MP, Klinedinst MA. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. J Psychopharmacol December 2016 30: 1181-1197, doi:10.1177/0269881116675513
Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, Menenga SE, Belser A, Kalliontzi K, Babb J, Su Z, Corby P, Schmidt BL. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. (2016) J Psychopharmacol December 2016 30: 1165-1180, doi:10.1177/0269881116675512
Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL, Greer GR. (2011) Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer. Arch Gen Psychiatry. 2011;68(1):71-78. doi:10.1001/archgenpsychiatry.2010.116.

Heffter Review Volume 1

Table of Contents
1. What is the Heffter Research Institute?
2. List of Contributors
3. Forward
4. Preface
5. Antiquity of the Use of New World Hallucinogens
  Richard Evans Schultes, Ph.D.
6. Psychiatric Research with Hallucinogens: What have we learned?
  Charles S. Grob, M.D.
7. Recent Advances and Concepts in the Search for Biological Correlates of hallucinogen-induced Altered States of Consciousness
  Franz X. Vollenweider, M.D.
8. Why Study Hallucinogenic Drugs in Animals?
  Mark A. Geyer, Ph.D.
9. The Medicinal Chemistry of Phenethylamine Psychedelics
  David E. Nichols, Ph.D.
10. Are The “Entactogens” a Distinct Psychoactive Substance Class?
  E. Gouzoulis-Mayfrank, M.D. and Leo Hermle, M.D.
11. Flashbacks in Theory and Practice
  Lin S. Myers, Shelly S. Watkins, and Thomas J. Carter
12. Ten Year Study of Ketamine Psychedelic Therapy (KPT) of Alcohol Dependence
  Evgeny M. Krupitsky, M.D., Ph.D. and A. Ya. Grinenko, M.D., Ph.D.
13. New Views of Timeless Experiences: Contemporary Research on the Nature and Significance of Transpersonal Experiences
  Roger Walsh, M.D.
14. The Scientific Investigation of Ayahuasca: A Review of Past and Current Research
  Dennis J. McKenna, Ph.D., J.C. Callaway, Ph.D and Charles S. Grob, M.D. .
Heffter Review Volume 2

Table of Contents
1. The Future of Mind Science (pp:1-5)
  John Horgan
2. Visions of the Night:Western Medicine Meets Peyote 1887 —1899 (pp:6-52)
  Daniel M.Perrine,Ph.D.
3. Acute Psychological and Neurophysiological Effects of MDMA in Humans (pp:53-63)
  Franz X.Vollenweider,M.D.,Mark Geyer,Ph.D.,George Greer,M.D.
4. Differential Actions of an Entactogen Compared to a Stimulant and a Hallucinogen
  in Healthy Humans (pp:64-72)
  Ephrosyne Gouzoulis-Mayfrank.M.D.
5. Serotonin Receptor Signaling and Hallucinogen Action (pp:73-79)
  Charles D.Nichols,Ph.D.,Elaine Sanders-Bush,Ph.D.
6. LSD and its Lysergamide Cousins (pp:80-87)
  David E.Nichols,Ph.D.
7. Ketamine-Assisted Psychotherapy (KPT)of Heroin Addiction:
  Immediate Effects and Six Month Follow-up (pp:88-101)
  Evgeny M.Krupitsky,M.D.,Ph.D., Andrey M.Burakov,M.D.,Ph.D.,
  Tatyana N.Romanov,Ph.D., Alexander Y.Grinenko,M.D.,Ph.D.,
  Rick J.Strassman,M.D.
List of authors:

Burakov,Andrey M.,M.D.,Ph.D.,Research Laboratory,Leningrad Regional Dispensary of Narcology,Leningrad Region,Russia

Geyer,Mark A.,Ph.D.,Department of Psychiatry,School of Medicine, University of California at San Diego,La Jolla,California

Gouzoulis-Mayfrank,Euphrosyne,M.D.,Psychiatric Department of the Technical University (RWTH),D-52074 Aachen,Germany

Grinenko,Alexander Y.,M.D.,Ph.D.,Research Laboratory,Leningrad Regional Dispensary of Narcology,Leningrad Region,Russia

Greer,George R.,M.D.,Heffter Research Institute,Santa Fe,New Mexico Horgan,John,science writer,Garrsion,New York

Krupitsky,Evgeny M.,M.D.,Ph.D.,Research Laboratory,Leningrad Regional Dispensary of Narcology,Leningrad Region,Russia

Nichols,Charles D.,Ph.D.,Department of Pharmacology,Vanderbilt University School of Medicine,Nashville,Tennessee

Nichols,David E.,Ph.D.,Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmacal Sciences,Purdue University,West Lafayette,Indiana

Perrine,Daniel M.,M.Div.,Ph.D.Associate Professor of Chemistry,Loyola College in Maryland,Baltimore,Maryland

Romanov,Tatyana N.,Ph.D.,Research Laboratory,Leningrad Regional Dispensary of Narcology,Leningrad Region,Russia

Sanders-Bush,Elaine,Ph.D.,Department of Pharmacology,Vanderbilt University School of Medicine,Nashville,Tennessee

Strassman,Rick J.,M.D.,Department of Psychiatry,University of New Mexico School of Medicine,Albuquerque,New Mexico

Vollenweider,Franz X.,M.D.,Psychiatric University Hospital,Clinical Research Unit, University of Zurich,CH-8029 Zurich,Switzerland

PUBLICATIONS

Heffter Research by Category

CANCER, DEPRESSION, OCD & HEADACHE

Addiction

Spirituality

Neuroscience

Heffter Review

Heffter Review Volume 1

Heffter Review Volume 2